Abstract:Sepsis accounts for the majority of deaths in critically ill patients. Symptoms of septic disease are often associated with monocyte/macrophage desensitization. In the current study, impaired macrophage function was determined in a sepsis mouse model with decreased cytokine release and weak phagocytosis, coinciding with ectopic elevation of serum-ROS levels. Furthermore, in the experimental cell model, RAW264.7 macrophages displayed a "deactivated" phenotype, characterized by impaired inflammatory and phagocytosis function. Cellular anti-oxidative proteins were further investigated; lipopolysaccharide (LPS)- and H2O2-treated cells exhibited lower ratio of reductive-to-oxidized glutathione as compared with LPS-treated cells only, without inducing cell death. 2-DE and MALTI-TOF/TOF were employed to illustrate protein expression differentiation patterns. A total of 33 proteins were found to be differently expressed Among them, 33% of proteins were associated with oxidative stress. We further investigated the role of the ROS/LPS/Toll-like receptor 4 (TLR4) axis in modulating the immunosuppression during sepsis. LPS- and H2O2-treated macrophages demonstrated decreased cytokine release, whereas TLR4 expression was upregulated. Western blot analysis showed decreased levels of phosphorylation of MAP kinases and I kappa B. Electrophoretic mobility shift assay analysis demonstrated attenuated DNA-binding activities of AP-1 and NF-kappa B, as compared with those of their control. Collectively, these findings indicate that ROS mediates critical aspects of innate immunity that result in an immunocompromised state through an imbalance of cellular oxidation/reduction during sepsis.

Free Radicals, Mitochondrial Dysfunction and Sepsis-induced Organ Dysfunction: A Mechanistic Insight

Endothelial Cell Dysfunction and Targeted Therapeutic Drugs in Sepsis

Oxidative stress and endothelial dysfunction during sepsis

The Interplay of Oxidative Stress and ROS Scavenging: Antioxidants as a Therapeutic Potential in Sepsis

Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention

Progress of Antioxidant Therapy in Sepsis

Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation

Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review

Molecular mechanisms of organ damage in sepsis: an overview

Mitochondrial dysfunction and resuscitation in sepsis

From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Sepsis induced myocardial mitochondrial oxidative damage in the elderly

Neutrophil extracellular traps and organ dysfunction in sepsis

Redox Imbalance Provokes Deactivation of Macrophages in Sepsis

The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.

From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis

Potential Role of Reactive Oxygen Species in Pancreatitis-Associated Multiple Organ Dysfunction

Mitochondrial Damage in Sepsis

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives